Volitionrx (VNRX) Total Current Liabilities (2011 - 2025)

Volitionrx has reported Total Current Liabilities for 11 years, with the latest figure at $12.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 56.99% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (up 56.99% YoY), and the FY2025 full-year result was $12.2 million, up 56.99% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $12.2 million, up from $11.4 million in the prior quarter.
• The five-year high for Total Current Liabilities was $31.5 million in Q1 2024, with the low at $5.4 million in Q2 2021.
• Historically, Total Current Liabilities has averaged $15.3 million across 5 years, with a median of $17.0 million in 2022.
• Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 221.42% — and 2025, when it sank 73.73%.
• Volitionrx's Total Current Liabilities stood at $6.5 million in 2021, then surged by 166.83% to $17.4 million in 2022, then slumped by 48.56% to $8.9 million in 2023, then declined by 12.89% to $7.8 million in 2024, then surged by 56.99% to $12.2 million in 2025.
• The last three Total Current Liabilities figures came in at $12.2 million (Q4 2025), $11.4 million (Q3 2025), and $9.2 million (Q2 2025), per Business Quant data.